Evolus Total Assets 2016-2024 | EOLS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evolus total assets from 2016 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evolus total assets from 2016 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$202.2B
Stryker (SYK)	$143.3B
Boston Scientific (BSX)	$130.1B
Medtronic (MDT)	$112.5B
EssilorLuxottica (ESLOY)	$111.7B
Lonza Group Ag (LZAGY)	$45.4B
Haleon (HLN)	$43.5B
GE HealthCare Technologies (GEHC)	$39.3B
ResMed (RMD)	$37B
Terumo (TRUMY)	$29.6B
Koninklijke Philips (PHG)	$25B
Zimmer Biomet Holdings (ZBH)	$21.5B
Insulet (PODD)	$18.8B
Baxter (BAX)	$17.7B
Smith & Nephew SNATS (SNN)	$10.6B
Bio-Rad Laboratories (BIO)	$10.3B
BellRing Brands (BRBR)	$9.1B
Demant (WILYY)	$8.4B
Lantheus Holdings (LNTH)	$6.1B
Haemonetics (HAE)	$4.5B
TG Therapeutics (TGTX)	$4.5B
ICU Medical (ICUI)	$4.3B
Prestige Consumer Healthcare (PBH)	$4B
Perrigo (PRGO)	$3.6B
Neogen (NEOG)	$3.5B
Envista Holdings (NVST)	$3.5B
Agios Pharmaceuticals (AGIO)	$3.4B
GN Store Nord (GNNDY)	$3B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.9B